Article

Combined vitrectomy, phaco system launched

A combined vitrectomy and phacoemulsification system (Stellaris Procedural Choice Vision Enhancement System, Bausch + Lomb) has been launched worldwide.

Aliso Viejo, CA-A combined vitrectomy and phacoemulsification system (Stellaris Procedural Choice Vision Enhancement System, Bausch + Lomb) has been launched worldwide.

The system replaces the company's microsurgical system (Millennium).

"When we spoke with the surgeons about the type of device they prefer, they emphasized how important it was to keep this device intuitive for the surgeon," said Russ Finlay, global marketing director, vitreoretinal business, Bausch + Lomb. "As a result, we designed the [system] for simplicity and efficiency, which lets the surgeon keep his or her mind on the patient and not the system set-up."

The system is designed to allow for fast set-up times and to occupy less operating room space. It has a dual light source and allows for surgeon-selected color filters to permit differentiated viewing. Also, according to the company, it accommodates phaco with a 1.8-mm incision and complements the company's 25-gauge system of instruments for retinal surgery, as well as 23-gauge and standard 20-gauge instruments.
 The system's proprietary tubing system is designed to allow for higher vacuum levels without compromising the stability of the chamber and overall safety.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.